Complex coronary disease in the post-SYNTAX era

    loading  Checking for direct PDF access through Ovid

Abstract

Should patients with high-risk coronary artery disease be treated with CABG or receive drug-eluting stents? The SYNTAX trial aimed to define the optimal revascularization strategy for patients with previously untreated three-vessel and/or left main coronary artery disease.

Related Topics

    loading  Loading Related Articles